Skip to main content
SpringerLink
Log in

Accuracy of Pathologic Techniques for the Diagnosis of Metastatic Melanoma in Sentinel Lymph Nodes

  • Original Article
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Sentinel lymph node (SLN) biopsy can accurately predict the presence of metastatic melanoma (MM) and has been used to identify patients with occult metastases. We present an analysis of the sensitivity and specificity of standard pathological techniques including intraoperative frozen section, permanent section, and immunohistochemistry in diagnosing MM within the SLN.

Methods: Sixty-nine consecutive patients with primary malignant melanoma thickness of .1.0 mm or thinner lesions invading the reticular dermis (Clark level IV) who underwent SLN biopsy were reviewed. Lymph nodes were examined intraoperatively by frozen section (FS), permanent section (H&E), and by immunohistochemistry (IH) for S-100 protein and HMB45.

Results: MM was found in 14 of 69 cases (20%). Permanent section H&E was performed in all cases, FS in 64 cases, and IH in 65 cases. FS analysis diagnosed MM in 4 of 14 cases (29%), was suspicious in 2 of 14 (14%), and falsely negative (FN) in 8 of 14 (57%) ultimately found to be positive with further workup. Within the FN group, MM was identified on review of the original FS slides in 3 of 8 cases (38%). Furthermore, within the FN group, the remaining 5 cases were identified as positive for MM by either permanent and/or deeper H&E sections and IH. IH alone with permanent H&E sections would have diagnosed MM in only 8 of 10 cases (80%) that were FS negative or suspicious. In no cases was MM identified by IH alone with the permanent and deeper H&E sections being negative. It is noteworthy that no false-positive cases were identified.

Conclusions: Intraoperative FS has low sensitivity in identifying MM within the SLN. IH alone does not increase the diagnostic yield. A combination of permanent H&E sections with deeper levels and S-100 and HMB45 IH dramatically increases the overall diagnostic sensitivity of SLN biopsy. Definitive diagnosis should await permanent H&E sections and IH staining.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Morton DL, Wen DR, Wong JH, et al. 1992 Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399.

    CAS  PubMed  Google Scholar 

  2. Albertini JJ, Cruse CW, Rapaport D, et al. 1996 Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223:217–224.

    CAS  PubMed  Google Scholar 

  3. Morton DL. 1997 Sentinel lymphadenectomy for patients with clinical stage I melanoma. J Surg Oncol 66:267–269.

    CAS  PubMed  Google Scholar 

  4. Thompson JF. 1997 Sentinel node biopsy. J Surg Oncol 66:270–272.

    CAS  PubMed  Google Scholar 

  5. Ross MI. 1997 Lymphatic mapping and sentinel node biopsy for early stage melanoma: How we do it at the M.D. Anderson Cancer Center. J Surg Oncol 66:273–276.

    CAS  PubMed  Google Scholar 

  6. Reintgen D. 1997 Lymphatic mapping and sentinel node harvest for malignant melanoma. J Surg Oncol 66:277–281.

    CAS  PubMed  Google Scholar 

  7. Karakousis CP, Najibi S, Trunk J. 1997 Sentinel node biopsy in malignant melanoma. J Surg Oncol 66:282–284.

    CAS  PubMed  Google Scholar 

  8. Emilia JCD, Lawrence W. 1997 Sentinel Lymph node biopsy in malignant melanoma: The standard of care? J Surg Oncol 65: 153–154.

    CAS  PubMed  Google Scholar 

  9. Kelly MC, Ollila DW, Morton DL. 1998 Lymphatic mapping and sentinel lymphadenectomy for melanoma. Semin Surg Oncol 14:283–290.

    Google Scholar 

  10. Gershenwald JE, Colome MI, Lee JE, et al. 1998 Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16:2253–2260.

    CAS  PubMed  Google Scholar 

  11. Cochran AJ, Wen D-R, Morton DL. 1988 Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma: An immunohistological study. Am J Surg Pathol 12: 612–618.

    Article  CAS  PubMed  Google Scholar 

  12. Urist MM, Maddox WA, Kennedy JE, Balch CM. 1983 Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 51:2152–2156.

    CAS  PubMed  Google Scholar 

  13. Coit DG, Rogatko A, Brennan MF. 1991 Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes: A multivariate analysis. Ann Surg 214:627–636.

    CAS  PubMed  Google Scholar 

  14. Reintgen D. 1996 Melanoma nodal mets: Biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5:104–120.

    Google Scholar 

  15. Veronesi U, Adamus J, Bandiera DC, et al. 1977 Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J ed 297:627–630.

    Article  CAS  Google Scholar 

  16. Karakousis CP, Seddiq MK, Moore R. 1980 Prognostic value of lymph node dissection in malignant melanoma. Arch Surg 115:719–722.

    CAS  PubMed  Google Scholar 

  17. Milton GW, Shaw HM, McCarthy WH, Pearson L, Balch CM, Soong SJ 1982 Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg 69:108–111.

    CAS  PubMed  Google Scholar 

  18. Balch CM. 1988 The role of elective lymph node dissection in melanoma: Rationale, results, and controversies. J Clin Oncol 6:163–172.

    CAS  PubMed  Google Scholar 

  19. McCarthy WH, Shaw HM, Cascinelli N, Santinami M, Belli F. 1992 Elective lymph node dissection for melanoma: Two perspectives. World J Surg 16:203–213.

    CAS  PubMed  Google Scholar 

  20. Drepper H, Ko¨hler CO, Bastian B, et al. 1993 Benefit of elective lymph node dissection in subgroups of melanoma patients. Cancer 72:741–749.

    CAS  PubMed  Google Scholar 

  21. Coates AS, Ingvar CI, Petersen-Schaefer I, et al. 1995 Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney melanoma unit from 1960 to 1991. J Am Coll Surg 180:402–409.

    CAS  PubMed  Google Scholar 

  22. Balch CM, Soong SJ, Bartolucci AA, et al. 1996 Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224:255–263.

    CAS  PubMed  Google Scholar 

  23. Leong SPL. 1998 The role of sentinel lymph nodes in human solid cancer. PPO Updates 12:1–12.

    Google Scholar 

  24. Joseph E, Brobeil A, Glass F, et al. 1998 Results of complete lymph node dissection in 83 patients with positive sentinel nodes. Ann Surg Oncol 5:119–125.

    CAS  PubMed  Google Scholar 

  25. Reintgen D, Cruse CW, Well K, et al. 1994 The orderly progression of melanoma nodal metastases. Ann Surg 220:759–767.

    CAS  PubMed  Google Scholar 

  26. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. 1996 Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Group Trail EST 1684. J Clin Oncol 14:7–17.

    CAS  PubMed  Google Scholar 

  27. Wagner JD, Davidson D, Coleman JJ, Hutchins G, Schauwecker D, Park H-M, Havlik RJ. 1999 Lymph node volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol 6:398–404.

    CAS  PubMed  Google Scholar 

  28. Wang X, Heller R, VanVoorhis N, et al. 1994 Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 220:768–774.

    CAS  PubMed  Google Scholar 

  29. Shivers SC, Wang W, Li W, et al. 1998 Molecular staging of malignant melanoma: Correlation with clinical outcome. JAMA 280:1410–1415.

    CAS  PubMed  Google Scholar 

  30. Cho KH, Hashimoto K, Taniguchi Y, Pietruk T, Zarbo RJ, An T. 1990 Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits. Cancer 66:765–771.

    CAS  PubMed  Google Scholar 

  31. Carson KF, Wen D-R, Li P-X, et al. 1996 Nodal nevi and cutaneous melanomas. Am J Surg Pathol 20:834–840.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Surgical Oncology, Roswell Park Cancer Institute, State University of New York at Buffalo, Buffalo, New York

    John F. Gibbs MD, Peter P. Huang MD & William G. Kraybill MD

  2. Division of Pathology, Roswell Park Cancer Institute, State University of New York at Buffalo, Buffalo, New York

    Paul J. Zhang MD & Richard Cheney MD

  3. Division of Pathology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14263

    Richard Cheney MD

Authors
  1. John F. Gibbs MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter P. Huang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul J. Zhang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William G. Kraybill MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard Cheney MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard Cheney MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gibbs, J.F., Huang, P.P., Zhang, P.J. et al. Accuracy of Pathologic Techniques for the Diagnosis of Metastatic Melanoma in Sentinel Lymph Nodes. Ann Surg Oncol 6, 699–704 (1999). https://doi.org/10.1007/s10434-999-0691-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-999-0691-2

Key Word

Search

Navigation